Detalhe da pesquisa
1.
The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozole.
BMC Cancer
; 17(1): 456, 2017 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28666422
2.
Effects of intravenous zoledronic acid and oral ibandronate on early changes in markers of bone turnover in patients with bone metastases from non-small cell lung cancer.
Int J Clin Oncol
; 16(3): 264-9, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21240683
3.
Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression.
Mol Diagn Ther
; 25(4): 409-424, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33974235
4.
Immune Checkpoint Inhibitor-Induced Pancreatic Injury: Imaging Findings and Literature Review.
Target Oncol
; 15(1): 25-35, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31925647
5.
Indolent peritoneal mesothelioma: PI3K-mTOR inhibitors as a novel therapeutic strategy.
ESMO Open
; 2(1): e000101, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28761723
6.
Strategies to modulate the immune system in breast cancer: checkpoint inhibitors and beyond.
Ther Adv Med Oncol
; 8(5): 360-74, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27583028
7.
Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC).
Eur J Cancer
; 46(9): 1703-11, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20399639
8.
Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy.
J Immunother
; 33(4): 435-41, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20386463
9.
Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients.
Cancer Biol Ther
; 9(9): 685-93, 2010 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20697196
10.
Second-line treatment of non small cell lung cancer by biweekly gemcitabine and docetaxel +/- granulocyte-macrophage colony stimulating factor and low dose aldesleukine.
Cancer Biol Ther
; 8(6): 497-502, 2009 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19242101
11.
Progression-free survival in bevacizumab-based first-line treatment for patients with metastatic colorectal cancer: is it a really good end point?
J Clin Oncol
; 27(28): e132-3; author reply e134-5, 2009 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19720898